Literature DB >> 20637200

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Hans L Tillmann1, Alex J Thompson, Keyur Patel, Manfred Wiese, Hannelore Tenckhoff, Hans D Nischalke, Yuliya Lokhnygina, Ulrike Kullig, Uwe Göbel, Emanuela Capka, Johannes Wiegand, Ingolf Schiefke, Wolfgang Güthoff, Kurt Grüngreiff, Ingrid König, Ulrich Spengler, Jeanette McCarthy, Kevin V Shianna, David B Goldstein, John G McHutchison, Jörg Timm, Jacob Nattermann.   

Abstract

BACKGROUND & AIMS: A single nucleotide polymorphism (SNP) upstream of the IL28B gene has been associated with response of patients with chronic hepatitis C to therapy with pegylated interferon and ribavirin and also with spontaneous clearance of acute hepatitis C in a heterogeneous population. We analyzed the association between IL28B and the clinical presentation of acute hepatitis C virus (HCV) infection in a homogeneous population.
METHODS: We analyzed the SNP rs12979860 in 190 women from the German anti-D cohort (infected with HCV genotype 1b via contaminated rhesus prophylaxis) and its association with spontaneous clearance. Clinical data were available in 136 women with acute infection who were also evaluated for IL28B genotype. Based on results of a TaqMan polymerase chain reaction assay, the rs12979860 SNP genotypes studied were C/C, C/T, or T/T.
RESULTS: Spontaneous clearance was more common in patients with the C/C genotype (43/67; 64%) compared with C/T (22/90; 24%) or T/T (2/33; 6%) (P < .001). Jaundice during acute infection was more common among patients with C/C genotype (32.7%) than non-C/C patients (with C/T or T/T) (16.1%; P = .032). In C/C patients, jaundice during acute infection was not associated with an increased chance of spontaneous clearance (56.3%) compared with those without jaundice (60.6%). In contrast, in non-C/C patients, jaundice was associated with a higher likelihood of spontaneous clearance (42.9%) compared with those without jaundice (13.7%).
CONCLUSIONS: The SNP rs12979860 upstream of IL28B is associated with spontaneous clearance of HCV. Women with the C/T or T/T genotype who did not develop jaundice had a lower chance of spontaneous clearance of HCV infection.
Copyright © 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637200     DOI: 10.1053/j.gastro.2010.07.005

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  115 in total

1.  Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.

Authors:  Fuat Kurbanov; Mohamed Abdel-Hamid; Rachel Latanich; Jacquie Astemborski; Mostafa Mohamed; Nabiel Mh Mikhail; Mai El-Daly; Sherif El-Kafrawy; David L Thomas; Chloe L Thio
Journal:  J Infect Dis       Date:  2011-09-20       Impact factor: 5.226

2.  IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.

Authors:  Vito Di Marco; Fabrizio Bronte; Vincenza Calvaruso; Marcello Capra; Zelia Borsellino; Aurelio Maggio; Maria Concetta Renda; Lorella Pitrolo; Maria Carmela Lo Pinto; Michele Rizzo; Flavia Fiorenza; Calogera Gerardi; Stefania Grimaudo; Antonietta Di Cristina; Massimo Levrero; Antonio Craxì
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

Review 3.  Genetics of IL28B and HCV--response to infection and treatment.

Authors:  C Nelson Hayes; Michio Imamura; Hiroshi Aikata; Kazuaki Chayama
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-29       Impact factor: 46.802

4.  Hepatobiliary quiz-3 (2012).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2012-09

Review 5.  Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.

Authors:  Tzu-Hao Lee; Hans L Tillmann; Keyur Patel
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

6.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

7.  Acute hepatitis C virus infection in a nurse trainee following a needlestick injury.

Authors:  Renzo Scaggiante; Liliana Chemello; Roberto Rinaldi; Giovanni Battista Bartolucci; Andrea Trevisan
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

8.  Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

Authors:  Jason Grebely; Jordan J Feld; Tanya Applegate; Gail V Matthews; Margaret Hellard; Alana Sherker; Kathy Petoumenos; Geng Zang; Ineke Shaw; Barbara Yeung; Jacob George; Suzy Teutsch; John M Kaldor; Vera Cherepanov; Julie Bruneau; Naglaa H Shoukry; Andrew R Lloyd; Gregory J Dore
Journal:  Hepatology       Date:  2013-05-08       Impact factor: 17.425

Review 9.  Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance.

Authors:  James Lara; Yury Khudyakov
Journal:  Antivir Ther       Date:  2012-12-07

10.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens.

Authors:  A J Muir; L Gong; S G Johnson; M T M Lee; M S Williams; T E Klein; K E Caudle; D R Nelson
Journal:  Clin Pharmacol Ther       Date:  2013-10-04       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.